Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

124 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of venetoclax monotherapy on the quality of life of patients with relapsed or refractory chronic lymphocytic leukemia: results from the phase 3b VENICE II trial.
Cochrane T, Enrico A, Gomez-Almaguer D, Hadjiev E, Lech-Maranda E, Masszi T, Nikitin E, Robak T, Weinkove R, Wu SJ, Sail KR, Pesko J, Pai M, Komlosi V, Anderson MA. Cochrane T, et al. Leuk Lymphoma. 2022 Feb;63(2):304-314. doi: 10.1080/10428194.2021.1986217. Epub 2021 Oct 11. Leuk Lymphoma. 2022. PMID: 34632935 Clinical Trial.
Molnupiravir is effective in patients with haematological malignancies.
Bołkun Ł, Pula B, Kołkowska-Leśniak A, Morawska M, Cichocka E, Charlinski G, Garus B, Giebel S, Piszcz J, Drozd-Sokolowska J, Kwiatkowski J, Biernat M, Hus I, Lech-Maranda E, Długosz-Danecka M, Giannopoulos K, Wróbel T. Bołkun Ł, et al. Int J Cancer. 2023 Sep 15;153(6):1251-1256. doi: 10.1002/ijc.34442. Epub 2023 Feb 7. Int J Cancer. 2023. PMID: 36691818
Targeting arginase-1 exerts antitumor effects in multiple myeloma and mitigates bortezomib-induced cardiotoxicity.
Ramji K, Grzywa TM, Sosnowska A, Paterek A, Okninska M, Pilch Z, Barankiewicz J, Garbicz F, Borg K, Bany-Laszewicz U, Zerrouqi A, Pyrzynska B, Rodziewicz-Lurzynska A, Papiernik D, Sklepkiewicz P, Kedzierska H, Staruch A, Sadowski R, Ciepiela O, Lech-Maranda E, Juszczynski P, Mackiewicz U, Maczewski M, Nowis D, Golab J. Ramji K, et al. Sci Rep. 2022 Nov 16;12(1):19660. doi: 10.1038/s41598-022-24137-1. Sci Rep. 2022. PMID: 36385153 Free PMC article.
A multicenter, open, non-comparative, phase II study of the combination of cladribine (2-chlorodeoxyadenosine), cytarabine, and G-CSF as induction therapy in refractory acute myeloid leukemia - a report of the Polish Adult Leukemia Group (PALG).
Wrzesień-Kuś A, Robak T, Lech-Marańda E, Wierzbowska A, Dmoszyńska A, Kowal M, Hołowiecki J, Kyrcz-Krzemień S, Grosicki S, Maj S, Hellmann A, Skotnicki A, Jedrzejczak W, Kuliczkowski K; Polish Adult Leukemia Group. Wrzesień-Kuś A, et al. Eur J Haematol. 2003 Sep;71(3):155-62. doi: 10.1034/j.1600-0609.2003.00122.x. Eur J Haematol. 2003. PMID: 12930315 Clinical Trial.
124 results